6don MSN
Biomarker analysis reveals clues to long-term survival in glioblastoma patients treated with SurVaxM
Results of a study led by researchers at Roswell Park Comprehensive Cancer Center are shedding light on why some newly ...
MedPage Today on MSN
'Blow Your Mind' Survival Improvement in Advanced, Mutated NSCLC
BERLIN -- Almost half of patients with advanced ALK -positive non-small cell lung cancer (NSCLC) have lived 7 years or longer ...
Real-world safety among patients with locally advanced or metastatic urothelial cancer (la/mUC) treated with first-line (1L) systemic regimens: Results from the ELEVATE UC-I study. Pooled analysis ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback